• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    FDA Approves New 2-Gram Presentation of Fibryga

    PR NEWSWIRE

    Grifols preps blood clot treatment approval push after ph. 3 win

    FIERCE PHARMA

    EMA Withdraws Authorisation of Mallinckrodt Pharma`s Raplixa (human fibrinogen)

    EMA

    EMA Statement on Withdrawing Mallinckrodt`s Raplixa (human fibrinogen)

    EMA

    EMA Assessmt & Procedural Steps for Mallinckrodt`s Raplixa (human fibrinogen)

    EMA

    Instituto Grifols, S.A. VeraSeal (human fibrinogen / human thrombin) Receives Approval In Europe

    EMA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.